Molecular evolution of the prostate cancer susceptibility locus RNASEL: Evidence for positive selection
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 8 (3) , 297-301
- https://doi.org/10.1016/j.meegid.2008.01.004
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A scientific journey through the 2-5A/RNase L systemCytokine & Growth Factor Reviews, 2007
- The role of inflammation and infection in the pathogenesis of prostate carcinomaBJU International, 2007
- Positive selection in the evolution of cancerBiological Reviews, 2006
- Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL VariantPLoS Pathogens, 2006
- A Map of Recent Positive Selection in the Human GenomePLoS Biology, 2006
- Pervasive Adaptive Evolution in Primate Seminal ProteinsPLoS Genetics, 2005
- HPC1/RNASEL Mediates Apoptosis of Prostate Cancer Cells Treated with 2′,5′-Oligoadenylates, Topoisomerase I Inhibitors, and Tumor Necrosis Factor-Related Apoptosis-Inducing LigandCancer Research, 2004
- Evidence of Positively Selected Sites in Mammalian α-DefensinsMolecular Biology and Evolution, 2004
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Host defense, viruses and apoptosisCell Death & Differentiation, 2001